Fu and colleagues [9] showed that the dual blockade of PI3K/HDAC potently inhibited the proliferation of pancreatic cancer cell lines, and Seidel and colleagues [10] showed that an HDAC6 inhibitor exhibited antitumor effects alone or in combination with other drugs, such as PI3K inhibitors, in various cancers. Here, HDAC6 is linked to cancer.